open access

Vol 24, No 1 (2019)
Published online: 2019-01-01
Submitted: 2018-02-06
Get Citation

Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies

Ignacio Morales-Orue, Rodolfo Chicas-Sett, Pedro C. Lara
DOI: 10.1016/j.rpor.2018.11.001
·
Rep Pract Oncol Radiother 2019;24(1):86-91.

open access

Vol 24, No 1 (2019)
Published online: 2019-01-01
Submitted: 2018-02-06

Abstract

Over the last decade, immunotherapy has emerged as a hopeful alternative in cancer therapy. Different drugs are used to stimulate the immune system and block negative immune regulatory pathways, known as “immune checkpoint inhibitors (ICI)”. Although clinical studies have reported efficacy and safety with the use of ICI, only a small group of patients have obtained a clinical benefit. Because of this, immunomodulation based on immunogenic cell death produced by radiotherapy (RT) has been well positioned as an alternative to increase the clinical effect on the primary neoplasm, but also in distant tumours, a phenomenon known as the “abscopal effect”. Early clinical outcomes with RT-ICI combination are promising, but the rate of abscopal responses remains low. These developments have opened a path to evaluate the use of nanotechnology as antigen-capturing nanoparticles (AC-NPs) for improving clinical outcomes in metastatic disease treated with RT-ICI. In this review, we aim to highlight the basic characteristics of nanoparticles and its application in oncology, focusing on their potential to enhance abscopal responses.

Abstract

Over the last decade, immunotherapy has emerged as a hopeful alternative in cancer therapy. Different drugs are used to stimulate the immune system and block negative immune regulatory pathways, known as “immune checkpoint inhibitors (ICI)”. Although clinical studies have reported efficacy and safety with the use of ICI, only a small group of patients have obtained a clinical benefit. Because of this, immunomodulation based on immunogenic cell death produced by radiotherapy (RT) has been well positioned as an alternative to increase the clinical effect on the primary neoplasm, but also in distant tumours, a phenomenon known as the “abscopal effect”. Early clinical outcomes with RT-ICI combination are promising, but the rate of abscopal responses remains low. These developments have opened a path to evaluate the use of nanotechnology as antigen-capturing nanoparticles (AC-NPs) for improving clinical outcomes in metastatic disease treated with RT-ICI. In this review, we aim to highlight the basic characteristics of nanoparticles and its application in oncology, focusing on their potential to enhance abscopal responses.

Get Citation

Keywords

Abscopal effect; Radiotherapy; Immunotherapy; Nanoparticles

About this article
Title

Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 24, No 1 (2019)

Pages

86-91

Published online

2019-01-01

DOI

10.1016/j.rpor.2018.11.001

Bibliographic record

Rep Pract Oncol Radiother 2019;24(1):86-91.

Keywords

Abscopal effect
Radiotherapy
Immunotherapy
Nanoparticles

Authors

Ignacio Morales-Orue
Rodolfo Chicas-Sett
Pedro C. Lara

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl